230 related articles for article (PubMed ID: 16802138)
21. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
[TBL] [Abstract][Full Text] [Related]
22. Early transtympanic steroid injection in patients with 'poor prognosis' idiopathic sensorineural sudden hearing loss.
Zhou Y; Zheng H; Zhang Q; Campione PA
ORL J Otorhinolaryngol Relat Spec; 2011; 73(1):31-7. PubMed ID: 21124045
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroid response and supporting cell antibody in autoimmune hearing loss.
Zeitoun H; Beckman JG; Arts HA; Lansford CD; Lee DS; El-Kashlan HK; Telian SA; Denny DE; Ramakrishnan A; Nair TS; Disher MJ; Sataloff RT; Fisher SG; Carey TE
Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):665-72. PubMed ID: 16103296
[TBL] [Abstract][Full Text] [Related]
24. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study.
Li P; Zeng XL; Ye J; Yang QT; Zhang GH; Li Y
Audiol Neurootol; 2011; 16(3):198-202. PubMed ID: 20948195
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate management of immune-mediated cochleovestibular disorders.
Sismanis A; Wise CM; Johnson GD
Otolaryngol Head Neck Surg; 1997 Feb; 116(2):146-52. PubMed ID: 9051055
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune inner ear disease.
Ruckenstein MJ
Curr Opin Otolaryngol Head Neck Surg; 2004 Oct; 12(5):426-30. PubMed ID: 15377956
[TBL] [Abstract][Full Text] [Related]
27. Intratympanic steroids for idiopathic sudden sensorineural hearing loss.
Fitzgerald DC; McGuire JF
Ann Otol Rhinol Laryngol; 2007 Apr; 116(4):253-6. PubMed ID: 17491522
[TBL] [Abstract][Full Text] [Related]
28. Review of the biologic agents used for immune-mediated inner ear disease.
Lobo D; García-Berrocal JR; Trinidad A; Verdaguer JM; Ramírez-Camacho R
Acta Otorrinolaringol Esp; 2013; 64(3):223-9. PubMed ID: 22770424
[TBL] [Abstract][Full Text] [Related]
29. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
[TBL] [Abstract][Full Text] [Related]
30. Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review.
Huang KH; Lin HC; Lin CD; Wu PC
Medicine (Baltimore); 2023 Jun; 102(23):e33889. PubMed ID: 37335659
[TBL] [Abstract][Full Text] [Related]
31. Cogan syndrome: An autoimmune eye and ear disease with systemic manifestations.
Bhandari GS; Duggal L; Jain N; Patel J
Natl Med J India; 2019; 32(6):349-351. PubMed ID: 33380629
[TBL] [Abstract][Full Text] [Related]
32. Intratympanic steroid injection as a salvage treatment for sudden sensorineural hearing loss.
Belhassen S; Saliba I
J Laryngol Otol; 2014 Dec; 128(12):1044-9. PubMed ID: 25399754
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss.
Swachia K; Sharma D; Singh J
J Basic Clin Physiol Pharmacol; 2016 Jun; 27(4):371-7. PubMed ID: 26812786
[TBL] [Abstract][Full Text] [Related]
34. Inner ear perfusion: indications and applications.
Hoffmann KK; Silverstein H
Curr Opin Otolaryngol Head Neck Surg; 2003 Oct; 11(5):334-9. PubMed ID: 14502063
[TBL] [Abstract][Full Text] [Related]
35. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.
Arslan N; Oğuz H; Demirci M; Şafak MA; İslam A; Kaytez SK; Samim E
Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047
[TBL] [Abstract][Full Text] [Related]
36. [Advances in diagnosis and therapies of immune-mediated inner ear diseases].
Wang H; Wang D; Wang Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Mar; 34(3):276-281. PubMed ID: 32791601
[No Abstract] [Full Text] [Related]
37. Late recovery with cyclosporine-A of an auto-immune sudden sensorineural hearing loss.
Di Leo E; Coppola F; Nettis E; Vacca A; Quaranta N
Acta Otorhinolaryngol Ital; 2011 Dec; 31(6):399-401. PubMed ID: 22323852
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness.
Gundogan O; Pinar E; Imre A; Ozturkcan S; Cokmez O; Yigiter AC
Otolaryngol Head Neck Surg; 2013 Nov; 149(5):753-8. PubMed ID: 23959817
[TBL] [Abstract][Full Text] [Related]
39. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
Plaza G; Herráiz C
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
[TBL] [Abstract][Full Text] [Related]
40. Intratympanic steroid therapy using the Silverstein Microwick™ for refractory sudden sensorineural hearing loss increases speech intelligibility.
Barriat S; van Wijck F; Staecker H; Lefebvre PP
Audiol Neurootol; 2012; 17(2):105-11. PubMed ID: 21860229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
